Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Atara Biotherapeutics, Inc. (ATRA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
4.7600+0.3600 (+8.18%)
At close: 04:00PM EST
4.8000 +0.04 (+0.84%)
After hours: 04:31PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/30/2022
Current
9/30/20226/30/20223/31/202212/31/20219/30/2021
Market Cap (intraday)
395.64M358.64M735.03M867.74M1.44B1.58B
Enterprise Value
191.31M91.33M450.68M524.94M1.11B1.22B
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected)
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
5.915.1831.0242.78111.69211.22
Price/Book (mrq)
2.111.393.283.104.664.77
Enterprise Value/Revenue
2.7020.488.7471.77147.33227.36
Enterprise Value/EBITDA
-0.66-1.10-14.68-6.06-12.23-14.80

Trading Information

Stock Price History

Beta (5Y Monthly) 1.01
52-Week Change 3-74.25%
S&P500 52-Week Change 3-10.18%
52 Week High 318.3100
52 Week Low 32.8300
50-Day Moving Average 34.2316
200-Day Moving Average 36.0005

Share Statistics

Avg Vol (3 month) 31.49M
Avg Vol (10 day) 3943.64k
Shares Outstanding 594.88M
Implied Shares Outstanding 6N/A
Float 871.96M
% Held by Insiders 10.63%
% Held by Institutions 1107.00%
Shares Short (Nov 14, 2022) 412.05M
Short Ratio (Nov 14, 2022) 48.48
Short % of Float (Nov 14, 2022) 413.03%
Short % of Shares Outstanding (Nov 14, 2022) 412.70%
Shares Short (prior month Oct 13, 2022) 411.9M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sep 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-420.84%

Management Effectiveness

Return on Assets (ttm)-45.58%
Return on Equity (ttm)-99.38%

Income Statement

Revenue (ttm)70.9M
Revenue Per Share (ttm)0.70
Quarterly Revenue Growth (yoy)-17.00%
Gross Profit (ttm)-229.6M
EBITDA -291.4M
Net Income Avi to Common (ttm)-247.08M
Diluted EPS (ttm)-3.6450
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)265.4M
Total Cash Per Share (mrq)2.8
Total Debt (mrq)76.7M
Total Debt/Equity (mrq)40.99
Current Ratio (mrq)3.92
Book Value Per Share (mrq)1.97

Cash Flow Statement

Operating Cash Flow (ttm)-247.82M
Levered Free Cash Flow (ttm)-160.78M
Advertisement
Advertisement